Histological analysis of the resected specimen diagnosed a Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) with mild lymphocytic submucosal inflammation. Crucially, there was no ...

Please provide your email address to receive an email when new articles are posted on . Survivors of blood or marrow transplant had increased risk for subsequent cutaneous malignant neoplasms. Basal ...

Trial investigators at City of Hope announce first-reported complete response from a CAR T therapy in a BPDCN patient, additional complete response achieved in AML Investigators found infusions of ...

Authors note that primary prophylaxis prevention is not feasible due to rarity of MPN. HealthDay News — Metformin use, including long-term use, is associated with significantly lower odds of ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of pivekimab sunirine (PVEK), an antibody-drug conjugate targeting CD123, in ...

Pillar Biosciences Announce Automated NGS Library Preparation Method on Hamilton Microlab STAR to Accelerate Myeloproliferative Neoplasm Research Pillar Biosciences Announce Automated NGS Library ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of pivekimab sunirine (PVEK), an antibody-drug conjugate targeting CD123, in ...

Contributions quantified for subsequent neoplasms in childhood cancer survivors. (HealthDay News) — Cancer treatments and genetic predisposition contribute to the risk of subsequent neoplasms (SNs) ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around ...